The cell culture reagents market is set to expand significantly, with an expected valuation of $11.04 billion by 2029 and a CAGR of 12.8% from 2022 to 2029, according to Meticulous Research®. Key drivers include rising demand for monoclonal antibodies and the growing prevalence of chronic diseases, coupled with increased funding for cell-based research.
Key Factors Driving Market Growth...